Richmond Pharmacology has a globally,
well recognised expertise in providing
consultancy and expert reports on cardiac
safety, the clinical conduct of intensive
ECG studies, core laboratory services
such as adjudication and the cardiology
over-reading of automated interval
measurements. We have expertise in
statistical analysis concentration-effect
modelling (CEM), reporting and publishing.
We have a 10 year track record in
conducting QTc studies. We can conduct
ICH E14 TQT studies or use CEM during
Japanese bridging and/or early SAD and
MAD studies eliminating the requirement
for a dedicated TQT study.
Richmond Pharmacology provides their clients with FDA compliant state of the art analysis methods, and provides the option to include a non-pharmacological method of proving assay sensitivity. Richmond’s unique and innovative approach means that we conduct our studies and prove assay sensitivity as a standard feature. This has provided quality data in many non-TQT studies eliminating the need for a dedicated TQT study.
Our core ECG laboratory provides
a centralised system for all our studies.
It has the longstanding commercial,
clinical and academic reputation of
excellence of St George’s University
in London, a world class provider in
cardiology. High-precision ECG acquisition
in our tried and tested clinic allows
meaningful ECG analysis with a smaller
sample size, making us the ideal choice
for the integration of cardiac safety in
FIH and MAD studies.
Richmond Pharmacology’s clinical facilities and the on-site core lab are a permanent set-up offering an unmatched focused work environment with no additional costs, thereby delivering value for money to pharmaceutical Sponsors. We are a leading publisher in this area and have publicly accessible credentials. We are proud of our integrity, our professional growth and experience in this field.
Richmond Pharmacology's Core ECG Laboratory was established in 2004 to provide centralized digital and manual ECG data analysis for Richmond Pharmacology's in house TQT trials, in addition to ECG reading, analysis and reporting for clinical trials.Read more ›
Richmond Pharmacology provides their clients with FDA compliant manual over-read QT interval measurement and analysis by a team of highly trained and experienced cardiologists.
Richmond Pharmacology's Core ECG Laboratory has worked with numerous clinical units worldwide and participated in 200 clinical trials sponsored by pharmaceutical companies.Read more ›
Thorough QT/QTc (TQT) studies are today an integral component in the development of new chemical entities (NCE) and on going drug development programmes.Read more ›